ELMS STEVE

CIK 00012501952 companiesNEW YORK, NY

SEC Profile

Transactions

Companies

Filings

CIK

0001250195

Recent Transactions

24 trades

Conversion
AMBIT BIOSCIENCES CORP
Common Stock
2013-05-21+227,801→ 314,369 total
Award
AMBIT BIOSCIENCES CORP
Stock Option (right to buy)
2013-05-21−7,085→ 7,085 total
Conversion
AMBIT BIOSCIENCES CORP
Common Stock
2013-05-21+352,047→ 1,122,809 total
Conversion
AMBIT BIOSCIENCES CORP
Series B Preferred Stock
2013-05-21−693,641→ 0 total
Conversion
AMBIT BIOSCIENCES CORP
Series D Preferred Stock
2013-05-21−2,474,300→ 0 total
Purchase
AMBIT BIOSCIENCES CORP
Common Stock
2013-05-21$8.00/sh+423,635→ 1,546,444 total
Conversion
AMBIT BIOSCIENCES CORP
Common Stock
2013-05-21+28,901→ 29,120 total
Conversion
AMBIT BIOSCIENCES CORP
Common Stock
2013-05-21+57,448→ 86,568 total
Conversion
AMBIT BIOSCIENCES CORP
Series D-2 Preferred Stock
2013-05-21−10,953,433→ 0 total
Conversion
AMBIT BIOSCIENCES CORP
Series E Preferred Stock
2013-05-21−8,449,121→ 0 total
Conversion
AMBIT BIOSCIENCES CORP
Series C Preferred Stock
2013-05-21−1,378,747→ 0 total
Conversion
AMBIT BIOSCIENCES CORP
Common Stock
2013-05-21+456,393→ 770,762 total
Conversion
AMBIT BIOSCIENCES CORP
Common Stock
2013-05-21+227,801→ 314,369 total
Conversion
AMBIT BIOSCIENCES CORP
Series B Preferred Stock
2013-05-21−693,641→ 0 total
Conversion
AMBIT BIOSCIENCES CORP
Common Stock
2013-05-21+456,393→ 770,762 total
Purchase
AMBIT BIOSCIENCES CORP
Common Stock
2013-05-21$8.00/sh+423,635→ 1,546,444 total
Conversion
AMBIT BIOSCIENCES CORP
Common Stock
2013-05-21+28,901→ 29,120 total
Conversion
AMBIT BIOSCIENCES CORP
Common Stock
2013-05-21+57,448→ 86,568 total
Conversion
AMBIT BIOSCIENCES CORP
Series D Preferred Stock
2013-05-21−2,474,300→ 0 total
Award
AMBIT BIOSCIENCES CORP
Stock Option (right to buy)
2013-05-21−7,085→ 7,085 total
Conversion
AMBIT BIOSCIENCES CORP
Series D-2 Preferred Stock
2013-05-21−10,953,433→ 0 total
Conversion
AMBIT BIOSCIENCES CORP
Series E Preferred Stock
2013-05-21−8,449,121→ 0 total
Conversion
AMBIT BIOSCIENCES CORP
Common Stock
2013-05-21+352,047→ 1,122,809 total
Conversion
AMBIT BIOSCIENCES CORP
Series C Preferred Stock
2013-05-21−1,378,747→ 0 total

Companies

Recent Filings

4
ELMS STEVE
May 21, 2013

Address

C/O AISLING CAPITAL 888 SEVENTH AVE., 30TH FLOOR

NEW YORK, NY, 10106

View on SEC.gov